| الوصف: |
Introduction: The measles-mumps-rubella vaccine is administered in Cuba with 99% vaccination coverage. Currently, the low immunogenicity of the strain of mumps with which it is manufactured is raised, so it is important to ensure the effectiveness of vaccines and their protective immune response.Objectives: Evaluate the behavior of the anti-rubella, anti-mumps and antimeasles antibody indices according to age, and to analyze the variation of the anti-mumps antibody response with respect to previous studies.Materials and methods: Serum and cerebro-spinal fluid samples from 42 pediatric patients with neuro-inflammatory processes were studied and total IgG and albumin and specific antibodies against the three viruses were quantified from immunoenzymatic assays ELISA type. Corresponding reibergrams and specific antibody indices were performed.Results: A sustained increase in antibodies against the ethree immunogens was observed in general, without significant differences due to age or notable postvaccination changes. There was a decrease in the antibody index as it moved away from the date of revaccination, so surveillance should be maintained in these age groups. The rate of production of anti-mumps antibodies was higher than against the other viruses, although not significantly. Conclusions: This vaccine guarantees protection by the uniformity of the memory induced immune response in all age groups. An increase in the protection of the studied population against mumps was demonstrated with respect to previous studies. ; Introducción: La vacuna contra sarampión-parotiditis-rubéola es administrada en Cuba con un 99 % de cobertura vacunal. Actualmente se plantea la baja inmunogenicidad de la cepa de parotiditis con que se fabrica por lo que resulta importante velar por la eficacia de las vacunas y su respuesta inmune protectora.Objetivos: Evaluar el comportamiento de los índices de anticuerpo antirubéola, antiparotiditis y antisarampión de acuerdo con la edad, y analizar la variación de la respuesta de anticuerpos ... |
| Relation: |
https://revibiomedica.sld.cu/index.php/ibi/article/view/1355/1099; Dubot-Pérès A, Mayxay M, Phetsouvanh R, Lee S, Rattanavong S, Vongsouvath M, et al. Management of Central Nervous System Infections, Vientiane, Laos, 2003-2011. EID Journal [Internet]. 2019 [citado 2020 Abr 15]; 25(5):898–910. Disponible en: https://doi.org/10.3201/eid2505.180914. 2. Ludlow M, Kortekaas J, Herden C, Hoffmann B, Tappe D, Trebst C, et al. Neurotropic virus infections as the cause of immediate and delayed neuropathology. Acta Neuropathol [Internet]. 2016 [citado 2020 Abr 15]; 131(2). Disponible en: https://doi.org/10.1007/s00401-015-1511-3. 3. Klein RS, CA. H. Protective and Pathological Immunity during Central Nervous System Infections. Immunity [Internet]. 2017 [citado 2020 Jun 28]; 46(6):891-909. Disponible en: http://dx.doi.org/10.1016/j.immuni.2017.06.012. 4. Reyes Reyes E, Hernández Torres R, Y. NN. Vigilancia inmunoepidemiológica del sarampión, rubéola, parotiditis, poliomielitis y tos ferina en la provincia Las Tunas, 2010-2013 Rev electron Zoilo [Internet]. 2014 [citado 2020 May 15]; 39(6). Disponible en: http://revzoilomarinello.sld.cu/index.php/zmv/article/view/226. 5. López Ambrón L, Egües Torres LI, Pérez Carreras A, Galindo Santana BM, Galindo Sardiña MA, Resik Aguirre S, et al. Experiencia cubana en inmunización, 1962–2016. Rev Panam Salud Publica [Internet]. 2018 [citado 2020 May 15]; 42:e34. Disponible en: http://iris.paho.org/xmlui/handle/123456789/34905. 6. ALERTA: Reporte epidemiológico semana No.33 para el nivel gerencial. . La Habana: Ministerio de Salud y Desarrollo Social. División de Enfermedades Notificables. Dirección de Vigilancia Epidemiológica.; 2010. 7. Alberto J. Dorta-Contreras, Elena Noris-García, Bu-Coifiú-Fanego R, Padilla-Docal B. Bases moleculares de la neuroimmunología. II Parte. Reibergrama y su uso en Neuroimmunología. Rev Cubana Pediatr [Internet]. 2005 [citado 2020 Abr 1]; 77(3). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75312005000300007. 8. Dorta AJ, Reiber H, Noris E, Padilla B, Coifiu RB, Robinson MA, et al. Neuroinmunología Básica. Academia, editor. La Habana2007. 9. Dorta-Contreras AJ. Nuevo Reibergrama para la evaluación de la síntesis intratecal de IgG3. Rev cubana Neurol [Internet]. 2001 [citado 2020 Abr 20]; 33(7):694-5. Disponible en: https://www.neurologia.com/articulo/2001069. 10. H. R. Cerebrospinal fluid data compilation and knowledge-based interpretation of bacterial, viral, parasitic, oncological, chronic inflammatory and demyelinating diseases. Diagnostic patterns not to be missed in neurology and psychiatry. Arq Neuro-Psiquiatr [Internet]. 2016 [citado 2020 May 2]; 74(4):337-50. Disponible en: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2016000400012&nrm=iso. . 11. Dorta-Contreras AJ, H. R. Teoría de la difusión molecular/flujo del líquido cefalorraquídeo. Rev Neurol [Internet]. 2004 [citado 2020 May 2]; 39(9):17-40. Disponible en: https://pdfs.semanticscholar.org/4671/03e3eb927ef58d5ef31e5516e7694d9cccb4. 12. SERION ELISA classic Mumps Virus. Disponible en: https://www.serion-diagnostics.de/en/products/serion-elisa-classic-antigen/mumps-virus/. 13. ELISA Enzygnost anti-VZV/IgG. Disponible en: https://www.bioz.com/result/elisa%20enzygnost%20anti%20vzv%20igg/product/Siemens%20Healthineers. 14. Enzygnost Anti-measles Virus/IgG. Disponible en: https://www.bioz.com/result/enzygnost%20anti%20measles%20virus%20igg/product/Siemens%20AG. 15. H. R. Knowledge-base for interpretation of Cerebrospinal fluid data patterns- Essentials in Neurology and Psychiatry. Arq Neuropsiquiatr [Internet]. 2016 [citado 2020 May 2]; 74(6):501-12. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/27332077. 16. Castillo-González W, González-Losada C, Iglesias-González IM, AJ. D-C. Pesquisa inmuno-epidemiológica en niños con meningoencefalitis vírica vacunados contra la parotiditis, rubéola y sarampión. Vaccimonitor [Internet]. 2019 [citado 2020 May 12]; 28:19-28. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2019000100019&nrm=iso. 17. Cruz-Quevedo M, Castillo-González W, AJ. D-C. IgG anti-Toxoplasma gondii antibody index as a measure of the naturally-adquired immune intrathecal response in neuroepidemiological study. Rev Cubana Invest Bioméd [Internet]. 2019 [citado 2020 Jun 12]; 38(3). Disponible en: https://www.researchgate.net/publication/335893444_IgG_anti-Toxoplasma_gondii_antibody_index_as_a_measure_of_the_naturally-adquired_immune_intrathecal_response_in_neuroepidemiological_study. 18. Ribas MdlÁ, Galindo M, Valcárcel M, García D, Rodríguez C, Y. T. Presencia de anticuerpos a sarampión, rubéola y parotiditis en una población cubana de 7 meses a 23 años. Rev Cubana Med Trop [Internet]. 2004 [citado 2020 Abr 19]; 56(3):192-6. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0375-07602004000300007&nrm=iso. 19. Robinson-Agramonte M, Hansotto R, Cabrera-Gomez J, R. G. Intrathecal polyspecific immune response to neurotropic viruses in multiple esclerosis: a comparative report from Cuban patients. Acta Neurol Scand [Internet]. 2007 [citado 2020 May 15]; 115(5):312-8. Disponible en: https://doi.org/10.1111/j.1600-0404.2006.00755.X.; https://revibiomedica.sld.cu/index.php/ibi/article/view/1355 |